Sort
34,240 grants matching “atherosclerosis”
Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHS
$979,543Ramnik J Xavier · Broad Institute, Inc. · R01 · FY2024 · HL
In-vitro and Pre-clinical Translational Studies of Inflammation and Atherosclerosis
$979,351Nehal Mehta · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Proteomic Markers of Arteriosclerosis
$979,134Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2006 · HL
Clinical Center for Look AHEAD: Health in Diabetes
$979,091University Of Alabama At Birmingham · U01 · FY2000 · DK
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$979,027Ira A Tabas · Columbia University Health Sciences · R35 · FY2020 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$978,869Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL
Macrophage Polarization in Response to Infections and Inflammation
$978,019Pradipta Ghosh · University Of California, San Diego · R01 · FY2022 · AI
Epidemiology of Age-related Macular Degeneration and Other Retinal Diseases - Coordinating Center
$978,005Ronald Gangnon · University Of Wisconsin-Madison · U10 · FY2016 · EY
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$977,964Tomas G Neilan · Massachusetts General Hospital · R01 · FY2023 · HL
National Resource for Translational and Developmental Proteomics
$977,670Neil L Kelleher · Northwestern University · P41 · FY2019 · GM
MESA
$977,637Gregory L Burke · Wake Forest University · N01 · FY2014 · HL
Genetic Determinants of PAD
$977,500John P Cooke · Stanford University · R01 · FY2006 · HL
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$976,789Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2016 · CA
Regulation of lipid metabolism by miRNAs
$975,803Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$975,803Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Atherosclerosis Risk in Communities Study (ARIC)
$975,789Daniel W Jones · Mississippi University For Women · N01 · FY2009 · HL
Clinical Center for Look AHEAD: Health in Diabetes
$975,674St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2003 · DK
Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases
$974,635Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium
$974,558Sudha Seshadri · University Of Texas Hlth Science Center · UH3 · FY2020 · NS
Clinical Center for Look AHEAD: Health in Diabetes
$972,244University Of Colorado Denver · U01 · FY2000 · DK
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), COORDINATING CENTER - TASK AREA A - CORE STUDY OPERATIONS
$971,789Robyn Leagh McClelland · University Of Washington · N01 · FY2025 · HL
Systems Biology Analyses for Hemodynamic Regulation of Vascular Homeostasis
$971,509John Y-J Shyy · University Of California, San Diego · R01 · FY2024 · HL
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$971,495Tomas G Neilan · Massachusetts General Hospital · R01 · FY2024 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,355Ira A Tabas · Columbia University Health Sciences · R35 · FY2021 · HL
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
$971,347Ira A Tabas · Columbia University Health Sciences · R35 · FY2022 · HL